Andrew Tsai

Jefferies & Co.

Recent Articles

Pharma Stock Nears FDA Approval 05/14/2024

According to a Jefferies & Co. research note, Verona Pharma Plc. is at the final stretch for its FDA approval.

Biotech Co. Positioned for Ensifentrine Approval, Analyst Says 05/06/2024

According to a Jefferies & Co. research note, Verona Pharma Plc. has a 90-95% probability of success for PDUFA approval.

Analyst Says Pharma Co. Has No True Competitor 04/19/2024

Verona Pharma Plc. recently is gearing up for a potential FDA approval of its twice-daily ensifentrine, according to a Jefferies & Co. research note.